| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T350 |
0-168 |
Sentence |
denotes |
Human monoclonal antibodies that promote remyelination represent a new class of therapeutics for diseases such as MS, spinal cord injury, neurodegeneration, and stroke. |
| TextSentencer_T350 |
0-168 |
Sentence |
denotes |
Human monoclonal antibodies that promote remyelination represent a new class of therapeutics for diseases such as MS, spinal cord injury, neurodegeneration, and stroke. |
| T47869 |
0-168 |
Sentence |
denotes |
Human monoclonal antibodies that promote remyelination represent a new class of therapeutics for diseases such as MS, spinal cord injury, neurodegeneration, and stroke. |
